Stockreport

Cassava Sciences agrees to $40M SEC fine over Alzehimer's claims [Yahoo! Finance Canada]

Cassava Sciences, Inc.  (SAVA) 
Last cassava sciences, inc. earnings: 8/12 08:30 am Check Earnings Report
PDF This comes after the pharmaceutical company was charged for misleading claims about an Alzheimer's clinical trial. Market Domination Hosts Julie Hyman and Josh Lipton [Read more]